38 Results for "

AGT

" in MedChemExpress (MCE) Product Catalog:
Products (38)

38 Results for "AGT" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-W002585
CAS No.: 19916-73-5
Research Areas:  

Cancer

O6-Benzylguanine, a guanine analog, is the DNA repair enzyme O6-alkylguanine-DNA alkyltransferase (MGMT/AGT) inhibitor. O6-Benzylguanine acts as an AGT substrate, which transfers its benzyl group to the AGT cysteine residue, thereby irreversibly inactivating AGT and preventing DNA repair. O6-Benzylguanine induces tumor cell apoptosis. Antineoplastic activity .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-108764
CAS No.: 629167-92-6
Purity:  97.50%
Synonyms: ISIS 301012
Target:  

Apolipoprotein HCV

Research Areas:  

Metabolic Disease

Mipomersen sodium (ISIS 301012) is an antisense oligonucleotide inhibitor of apolipoprotein B (apoB). Mipomersen has anti-HCV effect and reduces the infectivity of the HCV. Mipomersen sodium can be used for the research of homozygous familial hypercholesterolemia (HoFH) .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-150738
CAS No.: 1146541-45-8
Purity:  93.63%
Research Areas:  

Inflammation/Immunology

ODN 2088 is a potent TLR3, TLR7 and TLR9 inhibitor. ODN 2088 shows no cytotoxic. ODN 2088 inhibits the release of IFN-α and IL-6 .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-150736
CAS No.: 1964506-29-3
Purity:  92.60%
ODN 20844, a guanine-modified inhibitory oligonucleotide (INH-ODN), is a TLR7 and TLR9 (Toll-like receptor) inhibitor, and its parent is INH-ODN 2088. ODN 20844 disrupts TLR7- and TLR9-mediated immune cell immune responses. ODN 20844 sequence: 5'-TCCTGGCGc7GGGAAGT-3' .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-148413
CAS No.: 331257-53-5
Purity:  90.35%
Synonyms: ISIS 3521 sodium
Target:  

PKC

Research Areas:  

Cancer

Aprinocarsen (ISIS 3521) sodium, a specific antisense oligonucleotide inhibitor of protein kinase C-alpha (PKC-α). Aprinocarsen sodium is a 20-mer oligonucleotide, it regulates cell differentiation and proliferation. Aprinocarsen sodium inhibits the growth of human tumor cell lines in nude mice. Aprinocarsen sodium shows the value as a chemotherapeutic compound of human cancers .
loading...
    loading...
Cat. No.: HY-P99530
CAS No.: 1815583-32-4
Synonyms: AGT-181; HIRMAb-IDUA

Target:  

Insulin Receptor

Research Areas:  

Metabolic Disease

Valanafusp alfa (AGT-181) is a chimeric monoclonal antibody that fuses human α-L-iduronidase (IDUA) and targets the human insulin receptor (HIR). Valanafusp alfa has brain penetrating properties, making it useful for research on mucopolysaccharidosis type I (MPS I) .
loading...
    loading...
Cat. No.: HY-143230
CAS No.: 890056-27-6
Synonyms: OGX-011
Target:  

Apoptosis

Research Areas:  

Cancer

Custirsen (OGX-011) is an antisense oligonucleotide that targets clusterin mRNA. Custirsen induces apoptosis by activating Bax, triggering mitochondrial translocation and cytochrome c release. Custirsen acts as a chemosensitizer, radiosensitizer and hormone sensitizer. Custirsen can be used in research related to prostate cancer, non-small cell lung cancer and metastatic breast cancer .
loading...
    loading...
Cat. No.: HY-147406
CAS No.: 2589926-20-3
Synonyms: ION-904
Tonlamarsen (ION-904) is a GalNAc-conjugated antisense oligonucleotide and Angiotensinogen synthesis inhibitor. Tonlamarsen specifically reduces the production of Angiotensinogen in the liver and plasma, and exhibits extremely low activity in the kidneys. Tonlamarsen can be used in research related to hypertension and heart failure .
loading...
    loading...
Cat. No.: HY-W002585R
CAS No.: 19916-73-5
Research Areas:  

Cancer

O6-Benzylguanine, a guanine analog, is the DNA repair enzyme O6-alkylguanine-DNA alkyltransferase (MGMT/AGT) inhibitor. O6-Benzylguanine acts as an AGT substrate, which transfers its benzyl group to the AGT cysteine residue, thereby irreversibly inactivating AGT and preventing DNA repair. O6-Benzylguanine induces tumor cell apoptosis. Antineoplastic activity .
loading...
    loading...
Cat. No.: HY-145649
CAS No.: 2380166-33-4
Synonyms: AD-85481; ALN-AGT
Target:  

Angiotensin Receptor

Research Areas:  

Cardiovascular Disease

Zilebesiran is a siRNA that reduce hepatic angiotensinogen levels through RNA interference. it is used for the study of mild to moderate Hypertension. Angiotensinogen is the predominant precursor of angiotensin peptides and a key regulator of systemic blood pressure.
loading...
    loading...
Cat. No.: HY-P5939
CAS No.: 82048-97-3
Target:  

Angiotensin Receptor

Research Areas:  

Cardiovascular Disease

Angiotensinogen (1-13) (human) is a fragment of the renin substrate angiotensinogen. Angiotensinogen is naturally occurring substrate for renin and a precursor for all angiotensin peptides .
loading...
    loading...
Cat. No.: HY-145649A
CAS No.: 2380166-34-5
Synonyms: AD-85481 sodium; ALN-AGT sodium
Zilebesiran (AD-85481; ALN-AGT) sodium is a long-acting liver-targeted small interfering RNA (siRNA) antihypertensive agent. Zilebesiran sodium binds to the hepatic asialoglycoprotein receptor (ASGPR), activates the RNA-induced silencing complex to degrade hepatic angiotensinogen mRNA, thereby inhibiting the gene expression and synthesis of angiotensinogen. Zilebesiran sodium dose-dependently reduces serum angiotensinogen levels and 24-hour ambulatory blood pressure, with its effect persisting throughout the circadian cycle. Zilebesiran sodium is applicable to research related to hypertension .
loading...
    loading...
Cat. No.: HY-150744
CAS No.: 1964506-30-6
Research Areas:  

Inflammation/Immunology

ODN 24888 is an guanine-modified inhibitory oligonucleotides (INH-ODN), shows potent inhibition on TLR7/TLR9-mediated signaling. ODN 24888 impairs IFN-α level and NF-κB activation, inhibits IL-6 release. ODN 24888 involves in immune and inflammatory responses, can be used as a vaccine adjuvant .
loading...
    loading...
Cat. No.: HY-19932
CAS No.: 1193902-95-2
Target:  

HCV Protease HCV

Research Areas:  

Infection

MK-2748 is a hepatitis C virus (HCV) NS3/4a protease inhibitor. MK-2748 exhibits broad-spectrum and potent antiviral activity, with nanomolar-level activity against all genotypes (gt1a-gt6) (IC₅₀ < 0.115 nM), showing only slightly weaker activity against gt3a (1.212 nM), and maintaining high inhibitory activity against drug-resistant mutant strains such as gt1b R155K (IC₅₀ = 0.032 nM) and D168Y (IC₅₀ = 0.057 nM). MK-2748 can be used in the research of HCV infection .
loading...
    loading...
Cat. No.: HY-RS00466
Research Areas:  

Others

AGT Human Pre-designed siRNA Set A contains three designed siRNAs for AGT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS17726
Research Areas:  

Others

Agt Mouse Pre-designed siRNA Set A contains three designed siRNAs for Agt gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-RS08412
Research Areas:  

Others

Mgmt Mouse Pre-designed siRNA Set A contains three designed siRNAs for Mgmt gene (Mouse), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-150740
Research Areas:  

Inflammation/Immunology

ODN 21595 is a Guanine-Modified TLR7 and TLR9 inhibitor. ODN 21595 inhibits the release of IFN-α and IL-6 with no cytotoxic. ODN 21595 reduces the expression of CD86 and HLA-DR. ODN 21595 has the potential for the research of systemic lupus erythematosus (SLE) .
loading...
    loading...
Cat. No.: HY-RS00473
Research Areas:  

Others

AGXT Human Pre-designed siRNA Set A contains three designed siRNAs for AGXT gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.

loading...
    loading...
Cat. No.: HY-106435
CAS No.: 79955-36-5
Research Areas:  

Cancer

Cystemustine is a DNA inhibitor (a chloroethyl nitrosourea, CENU). Cystemustine can cause DNA cross-linking, thereby inhibiting the proliferation of tumor cells. Cystemustine can also exert cytotoxic effects by interfering with the cell cycle, inducing cell re-differentiation, and altering phospholipid metabolism. Cystemustine exhibits high anti-tumor activity and a relatively short plasma half-life in mice. Cystemustine can be used for the study of various malignant tumors, including melanoma, glioma, renal cancer, head and neck cancer, and colorectal cancer, etc .
loading...
    loading...